Evidence map›Paper›PMID 40970536›Full record

Observational studyJournal of the American Heart Association2025

Associations of Immune Cell Subsets With Coronary Artery Calcium Incidence and Progression in the Multi-Ethnic Study of Atherosclerosis.

Riddhi D Patel, Petra Buzkova, Sally Huber, Alan Landay, Matthew Budoff, Joshua C Bis, Nels Olson, Stephen Rich, Susan R Heckbert, Ani Manichaikul and 8 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Riddhi D PatelNorthwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0002-9575-2189
Petra BuzkovaUniversity of Washington Seattle WA USA.ORCID 0000-0001-8299-4974
Sally HuberUniversity of Vermont Burlington VT USA.
Alan LandayUniversity of Texas Medical Branch Galveston TX USA.
Matthew BudoffLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Los Angeles CA USA.ORCID 0000-0002-9616-1946
Joshua C BisUniversity of Washington Seattle WA USA.ORCID 0000-0002-3409-1110
Nels OlsonUniversity of Vermont Burlington VT USA.ORCID 0000-0003-1192-9969
Stephen RichUniversity of Virginia Charlottesville VA USA.ORCID 0000-0003-3872-7793
Susan R HeckbertUniversity of Washington Seattle WA USA.ORCID 0000-0002-7100-512X
Ani ManichaikulUniversity of Virginia Charlottesville VA USA.ORCID 0000-0002-5998-795X
James FloydUniversity of Washington Seattle WA USA.ORCID 0000-0002-0365-9041
Russell P TracyUniversity of Vermont Burlington VT USA.ORCID 0000-0002-0080-2420
Bruce M PsatyUniversity of Washington Seattle WA USA.ORCID 0000-0002-7278-2190
Margaret F DoyleUniversity of Vermont Burlington VT USA.ORCID 0000-0001-6769-5386
Colleen M SitlaniUniversity of Washington Seattle WA USA.ORCID 0000-0001-7656-7482
Joseph A C DelaneyUniversity of Washington Seattle WA USA.ORCID 0000-0003-1771-1776
Alison E FohnerUniversity of Washington Seattle WA USA.ORCID 0000-0003-4231-3331
Matthew J FeinsteinNorthwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0002-8958-7666

Funding

Task Area A Core Study Operations.Task Area A shall encompass annual follow-up of cohort members, clinical endpoints ascertainment, study coordination activities, maintenance of the database and biosp75N92020D00001 · NHLBI · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, ROBYN LEAGH · 2020 to 2025
$17.2M
Plasma proteomics in CHS and population biologyR01HL144483 · NHLBI · UNIVERSITY OF WASHINGTON · PI DURDA, JON PETER, GERSZTEN, ROBERT E · 2019 to 2022
$6.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
TO EXERCISE OPTION PERIOD ONE (1) FOR TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.75N92020D00004 · NHLBI · NORTHWESTERN UNIVERSITY · PI SIEGEL, JONATHAN H · 2020 to 2025
$4.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00006 · NHLBI · UNIVERSITY OF MINNESOTA · PI PANKOW, JAMES S · 2020 to 2025
$4.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00003 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POST, WENDY S · 2020 to 2025
$3.8M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00007 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BERTONI, ALAIN GERALD · 2020 to 2025
$3.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00002 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHEA, STEVEN J · 2020 to 2025
$3.4M
Innate and adaptive immune-cell densities as risk factors for heart failureR01HL135625 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, TRACY, RUSSELL P · 2018 to 2021
$2.8M
T-cell subsets as CVD risk factors in CHS and MESAR01HL120854 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M, TRACY, RUSSELL P · 2014 to 2017
$2.6M
Integrated epidemiology of systemic and plaque-specific immunologic features of human atherosclerosisR01HL175893 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Matthew Joel Feinstein, Edward Benjamin Thorp · 2024 to 2026
$2.1M
NHLBI NIH HHS 75N92020D00001NHLBI NIH HHS 75N92020D00002NHLBI NIH HHS 75N92020D00003NHLBI NIH HHS 75N92020D00004NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS 75N92020D00006NHLBI NIH HHS 75N92020D00007NHLBI NIH HHS HHSN268201500003CNHLBI NIH HHS HHSN268201500003INHLBI NIH HHS R01 HL120854NHLBI NIH HHS R01 HL135625NHLBI NIH HHS R01 HL144483NHLBI NIH HHS R01 HL175893
6 · The paper itself

Abstract

backgroundLimited data exist on associations of immune cell subsets with longitudinal changes in subclinical coronary artery disease.

methodsIn the MESA (Multi-Ethnic Study of Atherosclerosis) study, we used a case-cohort approach to explore associations of 28 immune cell subsets measured at baseline (2000-2002) with longitudinal changes in coronary artery calcium (CAC). We examined incident CAC from examination 2 (2002-2004) through examination 5 (2010-2012) in participants with 0 CAC at baseline using multivariable-adjusted Cox regression. In participants with CAC >0 at baseline, we analyzed changes in CAC through examination 5 using multivariable-adjusted linear mixed models. Because no studies have investigated immune cells and longitudinal CAC changes, analyses were considered exploratory, with

resultsOf 975 participants with immune cells subsets and CAC measurements at baseline, 378 had CAC 0 at baseline (mean age, 58.4; 37.0% men) and 597 had CAC >0 at baseline (mean age, 65.7; 57.6% men). Natural killer cells were associated with higher incident CAC (hazard ratio [HR], 1.26 per SD higher natural killer cell proportion;

conclusionsNatural killer cells may be associated with incident CAC and T regulatory cells may be associated with attenuated CAC progression, among other findings. These warrant replication and experimental investigation.

Indexed as

Coronary Artery DiseaseCoronary VesselsKiller Cells, NaturalVascular CalcificationAgedCoronary AngiographyDisease ProgressionFemaleHumansIncidenceMaleMiddle AgedMonocytesProspective StudiesRisk FactorsUnited Statescoronary artery calciumimmune cellsinflammationsubclinical atherosclerosis

Identifiers

PMID40970536
PMCPMC12684560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.